These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26839079)

  • 21. Expression of hydrophilic surface proteins in infective stages of Leishmania donovani.
    Alce TM; Gokool S; McGhie D; Stäger S; Smith DF
    Mol Biochem Parasitol; 1999 Jul; 102(1):191-6. PubMed ID: 10477187
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.
    Lau YL; Thiruvengadam G; Lee WW; Fong MY
    Parasitol Res; 2011 Sep; 109(3):871-8. PubMed ID: 21455621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
    Abass E; Bollig N; Reinhard K; Camara B; Mansour D; Visekruna A; Lohoff M; Steinhoff U
    PLoS Negl Trop Dis; 2013; 7(7):e2322. PubMed ID: 23875052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short report: production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis.
    Takagi H; Islam MZ; Itoh M; Islam AU; Saifuddin Ekram AR; Hussain SM; Hashiguchi Y; Kimura E
    Am J Trop Med Hyg; 2007 May; 76(5):902-5. PubMed ID: 17488913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on cocktails of 31-kDa, 36-kDa and 51-kDa antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis.
    Kaur H; Thakur A; Kaur S
    Parasite Immunol; 2015 Apr; 37(4):192-203. PubMed ID: 25615543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate.
    Tandon R; Chandra S; Baharia RK; Misra P; Das S; Rawat K; Siddiqi MI; Sundar S; Dube A
    Parasitology; 2018 Apr; 145(4):508-526. PubMed ID: 28691653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.
    Nico D; Martins Almeida F; Maria Motta J; Soares Dos Santos Cardoso F; Freire-de-Lima CG; Freire-de-Lima L; de Luca PM; Maria Blanco Martinez A; Morrot A; Palatnik-de-Sousa CB
    Front Immunol; 2018; 9():967. PubMed ID: 29867949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
    Bhowmick S; Ravindran R; Ali N
    Infect Immun; 2008 Mar; 76(3):1003-15. PubMed ID: 18195029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with recombinant Leishmania donovani gamma-glutamylcysteine synthetase fusion protein protects against L. donovani infection.
    Henriquez FL; Campbell SA; Roberts CW; Mullen AB; Burchmore R; Carter KC
    J Parasitol; 2010 Oct; 96(5):929-36. PubMed ID: 20950100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
    Thakur A; Kaur H; Kaur S
    Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
    Das P; Paik D; Naskar K; Chakraborti T
    Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania.
    Al-Wabel MA; Tonui WK; Cui L; Martin SK; Titus RG
    Am J Trop Med Hyg; 2007 Dec; 77(6):1060-5. PubMed ID: 18165522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania infantum recombinant kinesin degenerated derived repeat (rKDDR): A novel potential antigen for serodiagnosis of visceral leishmaniasis.
    Dhom-Lemos L; Viana AG; Cunha JLR; Cardoso MS; Mendes TAO; Pinheiro GRG; Siqueira WF; Lobo FP; Teles LF; Bueno LL; Guimarães-Carvalho SF; Bartholomeu DC; Fujiwara RT
    PLoS One; 2019; 14(1):e0211719. PubMed ID: 30703138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.
    Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Gupta PN; Saha SK; Ali N
    Clin Diagn Lab Immunol; 1999 Mar; 6(2):231-5. PubMed ID: 10066659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice.
    Salari S; Sharifi I; Keyhani AR; Ghasemi Nejad Almani P
    Parasit Vectors; 2020 Aug; 13(1):415. PubMed ID: 32787908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of partial protection against Leishmania donovani by promastigote antigens in negatively charged liposomes.
    Afrin F; Anam K; Ali N
    J Parasitol; 2000 Aug; 86(4):730-5. PubMed ID: 10958448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani.
    Sivakumar R; Sharma P; Chang KP; Singh S
    Protein Expr Purif; 2006 Mar; 46(1):156-65. PubMed ID: 16172002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes.
    Afrin F; Ali N
    Infect Immun; 1997 Jun; 65(6):2371-7. PubMed ID: 9169776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
    Lau YL; Fong MY
    Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.